Traveler's Diarrhea Treatment Global Market Report 2025

Description

Traveler's diarrhea is a common illness that occurs when individuals consume contaminated food or water while traveling. It is typically marked by frequent, loose stools, abdominal cramps, and sometimes nausea or vomiting. Treatment focuses on rehydration with oral rehydration solutions, the use of anti-diarrheal medications such as loperamide, and antibiotics in more severe cases.

The primary types of drugs used to treat traveler's diarrhea include antibiotics, anti-diarrheal medications, and other drug types. Antibiotics work by treating bacterial infections, either killing bacteria or inhibiting their growth. These drugs are administered through various routes, including oral and parenteral, and are used in treating both adult and children's traveler's diarrhea. The main end users of these medications include hospitals, homecare settings, specialty clinics, and other healthcare providers.

The traveler's diarrhea treatment market research report is one of a series of new reports from The Business Research Company that provides traveler's diarrhea treatment market statistics, including the traveler's diarrhea treatment industry global market size, regional shares, competitors with the traveler's diarrhea treatment market share, detailed traveler's diarrhea treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the traveler's diarrhea treatment industry. This traveler's diarrhea treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The traveler's diarrhea treatment market size has grown strongly in recent years. It will grow from $1.47 billion in 2024 to $1.60 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth during the historic period can be attributed to the increasing cases of viral, bacterial, and parasitic infections, a rise in chronic diseases, greater awareness of travel-related illnesses, a higher prevalence of traveler's diarrhea, and an increase in food poisoning incidents.

The traveler's diarrhea treatment market size is expected to see strong growth in the next few years. It will grow to $2.17 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The projected growth in the forecast period can be attributed to the rising prevalence of food poisoning cases, an increasing number of celiac disease diagnoses, a higher demand for anti-diarrheal medications, the growing popularity of adventure and eco-tourism, and a rise in international travel. Key trends during this period include the development of novel treatments, the use of probiotics and microbiome-based therapies, advancements in rapid diagnostic tools, the introduction of vaccines for prevention, and the continued growth of gastrointestinal drugs.

The growing number of travelers is expected to drive the expansion of the traveler's diarrhea treatment market. Travelers are individuals who move from one location to another, typically for leisure, business, or other reasons. Factors contributing to the rise in travelers include increasing disposable incomes, the growth of budget airlines, simplified visa requirements, and the rising popularity of experiential tourism. Traveler's diarrhea treatments assist by quickly alleviating symptoms, preventing dehydration, and enabling faster recovery, allowing travelers to continue their trips with minimal disruption. For example, in March 2023, the Bureau of Transportation Statistics reported that U.S. airlines transported 853 million passengers in 2022, an increase of 194 million from the 658 million carried in 2021. Consequently, the surge in travel is driving the growth of the traveler's diarrhea treatment market.

The increasing number of food poisoning cases is also expected to fuel the growth of the traveler's diarrhea treatment market. Food poisoning occurs from consuming contaminated food or beverages, often due to bacteria, viruses, parasites, or toxins. The rise in food poisoning cases is linked to factors such as improper food handling, contamination by bacteria such as Salmonella and E. coli, inadequate refrigeration, and a higher consumption of processed and ready-to-eat foods. Treatments for traveler's diarrhea help manage food poisoning symptoms such as dehydration, nausea, and abdominal cramps through rehydration therapy, antimicrobial medications, and probiotics, promoting quicker recovery and reducing complications. In December 2024, the European Food Safety Authority reported that the EU saw 5,763 foodborne outbreaks in 2022, reflecting a 44% increase compared to 2021. As a result, the growing incidence of food poisoning is contributing to the growth of the traveler's diarrhea treatment market.

Companies in the traveler's diarrhea treatment market are also focusing on developing innovative products such as delayed-release tablets to enhance treatment efficacy and reduce dosing frequency. These tablets are designed to release active ingredients at specific times after ingestion, ensuring the medication reaches the intestines before dissolving, which helps treat traveler's diarrhea effectively while minimizing stomach irritation. For example, in September 2023, Adalvo Ltd., based in Malta, partnered with Cosmo Pharmaceuticals N.V., based in Ireland, to launch Rifamycin SV MMX 200 mg (Aemcolo). This medication treats traveler's diarrhea by delivering a non-absorbed antibiotic directly to the colon, alleviating symptoms while minimizing disruption to beneficial gut bacteria. This targeted approach offers effective relief with a lower risk of systemic side effects and multi-drug resistance.

Major players in the traveler's diarrhea treatment market are Johnson & Johnson Services Inc., Bayer AG, Sanofi SA, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., C.H. Boehringer Sohn AG & Co. KG, Astellas Pharma Inc., Aurobindo Pharma Limited, Lupin Pharmaceuticals Inc., Mallinckrodt plc, Glenmark Pharmaceuticals Ltd., Indivior plc, Immuron Limited, Valneva SE, Cosmo Pharmaceuticals N.V., Otsuka Pharmaceutical Co. Ltd., Lumen Bioscience Inc., RedHill Biopharma Ltd., Brown & Burk Pharmaceuticals Ltd., Scandinavian Biopharma Holding AB.

North America was the largest region in the traveler's diarrhea treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in traveler's diarrhea treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the traveler's diarrhea treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The traveler's diarrhea treatment market consists of revenues earned by entities by providing services such as probiotics and preventive supplements, telemedicine and online consultations, travel vaccinations and preventive care, medical insurance and assistance services. The market value includes the value of related goods sold by the service provider or included within the service offering. The traveler's diarrhea treatment market also includes sales of oral rehydration salts (ORS), antimotility agents, probiotics, and bismuth subsalicylate products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Traveler's Diarrhea Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on traveler's diarrhea treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for traveler's diarrhea treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The traveler's diarrhea treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Drug Type: Antibiotics; Anti-diarrheal; Other Drug Types
2) By Route Of Administration: Oral; Parenteral
3) By Application: Adult Traveler's Diarrhea; Children Traveler's Diarrhea
4) By End-Users: Hospitals; Homecare; Specialty Clinics; Other End-Users
Subsegments:
1) By Antibiotics: Fluoroquinolones; Macrolides; Rifamycins
2) By Anti-diarrheal: Loperamide; Bismuth Subsalicylate
3) By Other Drug Types: Oral Rehydration Therapy; Probiotics; Zinc Supplements
Companies Mentioned: Johnson & Johnson Services Inc.; Bayer AG; Sanofi SA; GlaxoSmithKline plc; Teva Pharmaceutical Industries Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r34171

1. Executive Summary

2. Traveler's Diarrhea Treatment Market Characteristics

3. Traveler's Diarrhea Treatment Market Trends And Strategies

4. Traveler's Diarrhea Treatment Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Traveler's Diarrhea Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Traveler's Diarrhea Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Traveler's Diarrhea Treatment Market Growth Rate Analysis
5.4. Global Traveler's Diarrhea Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Traveler's Diarrhea Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Traveler's Diarrhea Treatment Total Addressable Market (TAM)

6. Traveler's Diarrhea Treatment Market Segmentation

6.1. Global Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antibiotics
Anti-diarrheal
Other Drug Types
6.2. Global Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Parenteral
6.3. Global Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Adult Traveler's Diarrhea
Children Traveler's Diarrhea
6.4. Global Traveler's Diarrhea Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Homecare
Specialty Clinics
Other End-Users
6.5. Global Traveler's Diarrhea Treatment Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fluoroquinolones
Macrolides
Rifamycins
6.6. Global Traveler's Diarrhea Treatment Market, Sub-Segmentation Of Anti-diarrheal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Loperamide
Bismuth Subsalicylate
6.7. Global Traveler's Diarrhea Treatment Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Rehydration Therapy
Probiotics
Zinc Supplements

7. Traveler's Diarrhea Treatment Market Regional And Country Analysis

7.1. Global Traveler's Diarrhea Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Traveler's Diarrhea Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Traveler's Diarrhea Treatment Market

8.1. Asia-Pacific Traveler's Diarrhea Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Traveler's Diarrhea Treatment Market

9.1. China Traveler's Diarrhea Treatment Market Overview
9.2. China Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Traveler's Diarrhea Treatment Market

10.1. India Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Traveler's Diarrhea Treatment Market

11.1. Japan Traveler's Diarrhea Treatment Market Overview
11.2. Japan Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Traveler's Diarrhea Treatment Market

12.1. Australia Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Traveler's Diarrhea Treatment Market

13.1. Indonesia Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Traveler's Diarrhea Treatment Market

14.1. South Korea Traveler's Diarrhea Treatment Market Overview
14.2. South Korea Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Traveler's Diarrhea Treatment Market

15.1. Western Europe Traveler's Diarrhea Treatment Market Overview
15.2. Western Europe Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Traveler's Diarrhea Treatment Market

16.1. UK Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Traveler's Diarrhea Treatment Market

17.1. Germany Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Traveler's Diarrhea Treatment Market

18.1. France Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Traveler's Diarrhea Treatment Market

19.1. Italy Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Traveler's Diarrhea Treatment Market

20.1. Spain Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Traveler's Diarrhea Treatment Market

21.1. Eastern Europe Traveler's Diarrhea Treatment Market Overview
21.2. Eastern Europe Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Traveler's Diarrhea Treatment Market

22.1. Russia Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Traveler's Diarrhea Treatment Market

23.1. North America Traveler's Diarrhea Treatment Market Overview
23.2. North America Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Traveler's Diarrhea Treatment Market

24.1. USA Traveler's Diarrhea Treatment Market Overview
24.2. USA Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Traveler's Diarrhea Treatment Market

25.1. Canada Traveler's Diarrhea Treatment Market Overview
25.2. Canada Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Traveler's Diarrhea Treatment Market

26.1. South America Traveler's Diarrhea Treatment Market Overview
26.2. South America Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Traveler's Diarrhea Treatment Market

27.1. Brazil Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Traveler's Diarrhea Treatment Market

28.1. Middle East Traveler's Diarrhea Treatment Market Overview
28.2. Middle East Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Traveler's Diarrhea Treatment Market

29.1. Africa Traveler's Diarrhea Treatment Market Overview
29.2. Africa Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Traveler's Diarrhea Treatment Market Competitive Landscape And Company Profiles

30.1. Traveler's Diarrhea Treatment Market Competitive Landscape
30.2. Traveler's Diarrhea Treatment Market Company Profiles
- 30.2.1. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Traveler's Diarrhea Treatment Market Other Major And Innovative Companies

31.1. C.H. Boehringer Sohn AG & Co. KG
31.2. Astellas Pharma Inc.
31.3. Aurobindo Pharma Limited
31.4. Lupin Pharmaceuticals Inc.
31.5. Mallinckrodt plc
31.6. Glenmark Pharmaceuticals Ltd.
31.7. Indivior plc
31.8. Immuron Limited
31.9. Valneva SE
31.10. Cosmo Pharmaceuticals N.V.
31.11. Otsuka Pharmaceutical Co. Ltd.
31.12. Lumen Bioscience Inc.
31.13. RedHill Biopharma Ltd.
31.14. Brown & Burk Pharmaceuticals Ltd.
31.15. Scandinavian Biopharma Holding AB

32. Global Traveler's Diarrhea Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Traveler's Diarrhea Treatment Market

34. Recent Developments In The Traveler's Diarrhea Treatment Market

35. Traveler's Diarrhea Treatment Market High Potential Countries, Segments and Strategies

35.1 Traveler's Diarrhea Treatment Market In 2029 - Countries Offering Most New Opportunities
35.2 Traveler's Diarrhea Treatment Market In 2029 - Segments Offering Most New Opportunities
35.3 Traveler's Diarrhea Treatment Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer